Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2311 AL 2325

Portosystemic shunts: an underdiagnosed but treatable cause of neurological and psychiatric disorders

Degos B, Daelman L, Huberfeld G, Meppiel E, Rabier D, Galanaud D, Magis AS, Lyon-Caen O, Samuel D, Sedel F.

J Neurol Sci. 2012 Oct 15;321(1-2):58-64. doi: 10.1016/j.jns.2012.07.050. Epub 2012 Aug 17.

Parkinson's disease and parkinsonism: neuropathology

Dickson DW.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a009258. doi: 10.1101/cshperspect.a009258.

Programmed cell death in Parkinson's disease

Venderova K, Park DS.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a009365. doi: 10.1101/cshperspect.a009365.

Contribution of yeast models to neurodegeneration research

Pereira C, Bessa C, Soares J, Leão M, Saraiva L.

J Biomed Biotechnol. 2012;2012:941232. doi: 10.1155/2012/941232. Epub 2012 Jul 15.

Closing the gap between clinic and cage: sensori-motor and cognitive behavioural testing regimens in neurotoxin-induced animal models of Parkinson's disease

Pienaar IS, Lu B, Schallert T.

Neurosci Biobehav Rev. 2012 Nov;36(10):2305-24. doi: 10.1016/j.neubiorev.2012.07.009. Epub 2012 Aug 13.

Cognition and eye movements: assessment of cerebral dysfunction

White OB, Fielding J.

J Neuroophthalmol. 2012 Sep;32(3):266-73. doi: 10.1097/WNO.0b013e3182688230.

Recommendations for optimal ICD codes to study neurologic conditions: a systematic review

St Germaine-Smith C, Metcalfe A, Pringsheim T, Roberts JI, Beck CA, Hemmelgarn BR, McChesney J, Quan H, Jette N.

Neurology. 2012 Sep 4;79(10):1049-55. doi: 10.1212/WNL.0b013e3182684707. Epub 2012 Aug 22.

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Sáez-Valero J, Saka E, Urbani A, Vanmechelen E, Verbeek M, Visser PJ, Teunissen C.

Biomark Med. 2012 Aug;6(4):419-30. doi: 10.2217/bmm.12.46.

A fatal intoxication case involving ropinirole

Duband S, Bidat C, Gaillard Y, Rochet M, Camdessanche JP, Péoc'h M.

J Forensic Leg Med. 2012 Oct;19(7):422-5. doi: 10.1016/j.jflm.2012.04.013. Epub 2012 May 11.

Addictive behaviors and Parkinson's disease

Witjas T, Eusebio A, Fluchère F, Azulay JP.

Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):624-33. doi: 10.1016/j.neurol.2012.06.014. Epub 2012 Aug 24.

[Apathy and deep brain stimulation in Parkinson's disease]

Lozachmeur C, Drapier D.

Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):620-3. doi: 10.1016/j.neurol.2012.06.011. Epub 2012 Aug 24.

[Imaging non motor signs in Parkinson's disease]

Thobois S, Ballanger B, Poisson A, Broussolle E.

Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):576-84. doi: 10.1016/j.neurol.2012.05.007. Epub 2012 Aug 24.

Targeting disease through novel pathways of apoptosis and autophagy

Maiese K, Chong ZZ, Shang YC, Wang S.

Expert Opin Ther Targets. 2012 Dec;16(12):1203-14. doi: 10.1517/14728222.2012.719499. Epub 2012 Aug 27.

Current understanding of LRRK2 in Parkinson's disease: biochemical and structural features and inhibitor design

Ray S, Liu M.

Future Med Chem. 2012 Sep;4(13):1701-13. doi: 10.4155/fmc.12.110.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias